Case Study · Health & Healthcare
$150.9 Billion in Social Value Loss from Arthritis in Canada by 2055
A chronic-disease case assessed the long-run social value burden of arthritis in Canada.
Headline finding
-$150.9 billion per year
What the Work Shows
The analysis demonstrates how disease burden can be expressed in terms that connect health outcomes, household wellbeing and the cost of inaction.
This work follows consequences through the people affected, compares outcomes with a relevant counterfactual, and makes distributional effects visible rather than relying only on aggregate totals.
Explore the methodology →Why It Matters
Decision-makers can use this kind of evidence to understand both the scale of an outcome and who experiences it — a stronger basis for comparing options, communicating value and testing whether an intervention improves people's lives.
Your decision
Have a Similar Question?
Tell us what you need to compare, prove or understand. We will tell you what evidence is possible.